期刊文献+

系统性红斑狼疮合并冠状动脉疾病患者冠状动脉病变及临床分析 被引量:4

Clinical and coronary features of systemic lupus erythematosus patients with coronary artery disease
原文传递
导出
摘要 目的阐述系统性红斑狼疮(SLE)合并冠状动脉疾病患者的临床特征和冠状动脉表现。方法1999年1月至2009年10月在北京协和医院住院的年龄≥18岁的SLE患者共2877例,其中男性363例,女性2514例。对在SLE发病之后并发冠状动脉疾病的33例患者的临床资料及其中20例患者的冠状动脉病变特征进行回顾性分析。结果SLE患者出现冠状动脉疾病年龄23~74岁,平均(50.7±12.8)岁,SLE和冠状动脉疾病发病间隔平均(8.0±7.1)年。男性SLE患者冠状动脉疾病发生率有高于女性的趋势[2.48%(9/363)比0.95%(24/2514),P=0.022]。继发抗磷脂综合征(APS)患者冠状动脉疾病发生率明显增加[5.76%(8/139)比0.91%(25/2738),P〈0.001]。24例患者冠状动脉疾病的临床表现为心肌梗死;冠状动脉造影可见血管闭塞、狭窄、瘤样扩张和急性血栓形成,75.0%(15/20)的病例为多支病变。结论男性和继发抗磷脂综合征SLE患者冠状动脉疾病发生率高;SLE合并冠状动脉疾病者冠状动脉病变广泛,常常发生心肌梗死。 Objectives To observe the clinical and coronary" features of patients with systemic lupus erythematosus (SLE) and coronary artery disease (CAD). Methods Among 2877 SLE inpatients ( age ≥ 18 years, male 363, female 2514) admitted in the Peking Union Medical College Hospital between January 1999 to October 2009, 33 patients [ mean age (50. 7 ± 12.8) years] were diagnosed with CAD and coronary angiogram was available in 20 out of these 33 patients. Clinical and coronary features of these patients were retrospectively reviewed. Results The incidence of CAD was significantly higher in male SLE patients than in female patients [ 2.48% (9/363) vs. 0. 95% (24/2514), P = 0. 022]. Patients with secondary antiphospholipid syndrome were more likely to suffer from CAD [ 5.76% ( 8/139 ) vs. 0. 91% (25/2738), P 〈0. 001]. Myocardial infarction was the major form of CAD (24/33). Coronary artery angiographic changes included coronary stenosis and occlusions, coronary aneurysms and acute thrombosis and multi- vessel lesions was found in 75.0% (15/20) patients with SIrE and CAD. Conclusions Male SLE patients and patients with secondary antiphospholipid syndrome are at higher risk for CAD. Myocardial infarction and multi-vessel lesions are common in SLE patients with CAD.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2012年第5期382-385,共4页 Chinese Journal of Cardiology
关键词 红斑狼疮 系统性 冠状动脉疾病 冠状动脉造影术 抗磷脂综合征 Lupus erythematosus, systemic Coronary artery disease Coronary angiography Antiphospholipid syndrome
  • 相关文献

参考文献14

  • 1Goldberg R J, Urowitz MB, Ibanez D, et al. Risk factors for development of coronary artery disease in women with systemic lupus erythematosus. J Rheumatol, 2009,36:2454-2461.
  • 2Karrar A, Sequeira W, Block JA. Coronary artery disease in systemic lupus erythematosus: a review of theliterature. Semin Arthritis Rheum,2001,30:436-443.
  • 3Nikpour M, Urowitz MB, Ibafiez D, et al. Relationship between cardiac symptoms, myocardial perfusion defects and coronary angiography findings in systemic lupus erythematosus. Lupus, 2011,20:299-304.
  • 4Abusamieh M, Ash J. Atheroselerosis and systemic lupus erythematosus. Cardiol Rev,2004 ,12 :267-275.
  • 5Ippolito A, Petri M. An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol,2008 ,26 ( 5 Suppl 51 ) : S72-S79.
  • 6Ostanek L, Brzosko M, Fischer K, et al. Antiphospholipid syndrome and antiphospholipid antibodies as a risk factors of ischaemic heart disease and myocardial infarction in patients with systemic lupus erythematosus. Pol Arch Med Wewn, 2006,115 : 407-413.
  • 7叶益聪,张抒扬.系统性红斑狼疮与动脉粥样硬化[J].中华心血管病杂志,2008,36(2):190-192. 被引量:3
  • 8戴宇翔,张抒扬,杜臻雁.系统性红斑狼疮合并冠心病临床特点[J].中华内科杂志,2007,46(7):541-543. 被引量:9
  • 9中国成人血脂异常防治指南制定委员会.中国成人血脂异常防冶指南[J].中华心血管病杂志,2007,35:390-413.
  • 10Urowitz MB, Gladman D, Ibanez D, et al. Systemic lupus international collaborating clinics. Atherosclerotic vascular events in a multinational inception cohort of systemiclupus erythematosus. Arthritis Care Res (Hoboken) , 2010.62:881-887.

二级参考文献30

  • 1Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol, 1997, 145 : 408-415.
  • 2Roman M J, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med, 2003, 349 : 2399-2406.
  • 3Chung CP, Oeser A, Avalos I, et al. Cardiovaseular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus. Lupus, 2006, 15: 562-569.
  • 4El-Magadmi M, Bodill H, Ahmad Y, et al. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation, 2004, 110: 399-404.
  • 5Petri M, Spence D, Bone LR, et al. Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices. Medicine, 1992, 71: 291-302.
  • 6Bruce IN, Urowitz MB, Gladman DD, et al. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum, 2003, 48: 3159-3167.
  • 7Urowitz MB, Ibafiez D, Gladman DD. Atherosclerotic vascular events in a singh large lupus cohort : prevalence and risk factors. J Rheumatol, 2007, 34 : 70-75.
  • 8Doria A, Shoenfeld Y, Wu R, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis, 2003, 62: 1071-1077.
  • 9Borba EF, Bonfa E, Vinagre CG, et al. Chylomicron metabolism is markedly altered in systemic lupus erythematosus. Arthritis Rheum, 2000, 43 : 1033-1040.
  • 10McMahon M, Grossman J, FitzGerald J, et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum, 2006, 54: 2541-2549.

共引文献10

同被引文献72

  • 1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 2Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol, 1997,145:408-415.
  • 3Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheumatol, 1987, 14: S223-S226.
  • 4Petri M, Perez-Gutthann S, Spencc D, et al. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med, 1992, 93:513-519.
  • 5Bessant R, Hingorani A, Patel L, et al. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology ( Oxford ), 2004, 43 : 924- 929.
  • 6Toloza SM, Uribe AG, McGwin G Jr, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). X Ⅻ. Baseline predictors of vascular events. Arthritis Rheum, 2004, 50 : 3947-3957.
  • 7Urowitz MB, Ibafiez D, Gladman DD. Atheroselerotic vascular events in a single large lupus cohort : prevalence and risk factors. J Rheumatol, 2007, 34:70-75.
  • 8Urowitz MB, Gladman D, Ibafiez D, et al. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken), 2010, 62: 881-887.
  • 9Esdaile JM, Abrahamowiez M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum, 2001,44:2331-2337.
  • 10Bruce IN, Urowitz MB, Gladman DD, et al. Risk factors for coronary heart disease in women with systemic lupus e~ythematosus: the Toronto risk factor study. Arthritis Rheum, 2003, 48 : 3159-3167.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部